Table 3.
Anthropometric and Biochemical Measurements at Baseline and Change During Follow-up Stratified by Duration of T2D at Baseline (<3 Years or ≥3 Years).
| Variable | Baseline, Mean (SD) | Change, Mean (SD) | P |
|---|---|---|---|
| T2D <3 years | |||
| HbA1c, mmol/mol | 46.3 (10.1) | −1.0 (11.0) | .36 |
| LDL, mmol/L | 2.8 (1.0) | −0.3 (1.0) | <.05 |
| sBP, mm Hg | 135.9 (15.5) | −2.6 (13.5) | .06 |
| dBP, mm Hg | 79.2 (9.5) | −1.0 (8.3) | .23 |
| BMI, kg/m2 | 31.0 (5.1) | −0.6 (1.7) | <.05 |
| T2D ≥3 years | |||
| HbA1c, mmol/mol | 52.0 (12.6) | −0.8 (9.1) | .14 |
| LDL, mmol/L | 2.6 (1.2) | −0.1 (1.1) | <.05 |
| sBP, mm Hg | 134.9 (14.3) | −2.0 (14.0) | <.05 |
| dBP, mm Hg | 77.7 (8.5) | −1.7 (7.5) | <.05 |
| BMI, kg/m2 | 31.0 (5.7) | −0.5 (1.4) | <.05 |
Abbreviations: HbA1c, glycosylated hemoglobin A1; sBP, systolic blood pressure; dBP, diastolic blood pressure; LDL, low-density lipoprotein; BMI, body mass index.
a
P from independent-samples t test.